ENTRY       D10885                      Drug
NAME        Abaloparatide (USAN/INN);
            Tymlos (TN)
PRODUCT     TYMLOS (Radius Health)
FORMULA     C174H300N56O49
EXACT_MASS  3958.2705
MOL_WEIGHT  3960.5896
SEQUENCE    Ala Val Ser Glu His Gln Leu Leu His Asp Lys Gly Lys Ser Ile Gln
            Asp Leu Arg Arg Arg Glu Leu Leu Glu Lys Leu Leu Aib Lys Leu His
            Thr Ala
  TYPE      Peptide
CLASS       Hormonal agent
             DG01661  Parathyroid hormone and analog
            Musculo-skeletal system agent
             DG03232  Osteoporosis agent
REMARK      ATC code: H05AA04
            Chemical structure group: DG03050
            Product (DG03050): D10885<US> D11563<JP>
EFFICACY    Osteoporosis agent, Osteogenesis stimulant, Parathyroid hormone receptor 1 agonist
  DISEASE   Osteoporosis [DS:H01593]
COMMENT     Parathyroid hormone like hormone
            Treatment of osteoporosis
TARGET      PTH1R [HSA:5745] [KO:K04585]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H05 CALCIUM HOMEOSTASIS
               H05A PARATHYROID HORMONES AND ANALOGUES
                H05AA Parathyroid hormones and analogues
                 H05AA04 Abaloparatide
                  D10885  Abaloparatide (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Metabolic Bone Disease Agents
              Calcium Regulating Hormones
               Abaloparatide
                D10885  Abaloparatide (USAN/INN)
            Drug groups [BR:br08330]
             Hormonal agent
              DG01661  Parathyroid hormone and analog
               DG03050  Abaloparatide
                D10885  Abaloparatide
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG03050  Abaloparatide
                D10885  Abaloparatide
            Drug classes [BR:br08332]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D10885  Abaloparatide
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Parathyroid hormone
                PTH1R
                 D10885  Abaloparatide (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10885
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10885
            Drug groups [BR:br08330]
             Hormonal agent
              DG01661  Parathyroid hormone and analog
               DG03050  Abaloparatide
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG03050  Abaloparatide
DBLINKS     CAS: 247062-33-5
            PubChem: 336445203
///
